US Broker Ratings

Scholar Rock Holding Corporation (SRRK) Investor Outlook: A 37.5% Potential Upside Awaits

Scholar Rock Holding Corporation (NASDAQ: SRRK) is rapidly gaining attention in the biotechnology sector with its pioneering approach to targeting protein growth factors for treating serious diseases. Based in Cambridge,..

Sotera Health Company (SHC) Stock Analysis: Unlocking an 18.66% Potential Upside in the Healthcare Sector

Sotera Health Company (NASDAQ: SHC), a significant player in the healthcare sector’s diagnostics and research industry, presents an intriguing investment opportunity with a potential upside of 18.66%. With a market..

LivaNova PLC (LIVN) Stock Analysis: Exploring a 40.82% Potential Upside

LivaNova PLC (NASDAQ: LIVN), a prominent player in the healthcare sector, specializes in medical devices that cater to neurological and cardiac conditions. With a market capitalization of $2.37 billion, the..

Addus HomeCare Corporation (ADUS) Stock Analysis: Strong Buy Ratings Suggest 25% Upside Potential

Investors seeking opportunities in the healthcare sector may find Addus HomeCare Corporation (NASDAQ: ADUS) an intriguing option. With a current market capitalization of $2.01 billion, Addus stands out as a..

Harmony Biosciences Holdings, I (HRMY): Investor Outlook Reveals 40% Upside Potential

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) is making waves in the biotechnology sector, standing out with a market cap of $2.05 billion and a targeted focus on developing therapies for..

Certara, Inc. (CERT) Stock Analysis: Unlocking a 37.51% Upside Potential in a Transformative Healthcare Sector

Certara, Inc. (NASDAQ: CERT) represents a compelling opportunity for investors interested in the convergence of healthcare and technology. With its comprehensive suite of software solutions and services aimed at enhancing..

Vericel Corporation (VCEL) Stock Analysis: Exploring a 40% Potential Upside

Vericel Corporation (NASDAQ: VCEL) is making waves in the biotechnology sector, driving curiosity among investors seeking opportunities in the healthcare industry. With a market capitalization of $2.09 billion, Vericel is..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: Exploring a Potential 132% Upside in the Biotech Sector

For individual investors eyeing the dynamic biotech sector, Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) presents an intriguing opportunity. With a current market cap of $2.84 billion, this San Diego-based company is..

NewAmsterdam Pharma (NAMS): Investor Outlook on a Biotech with 77% Potential Upside

NewAmsterdam Pharma Company N.V. (NAMS), a Netherlands-based biopharmaceutical firm, is capturing the attention of investors with its promising pipeline in the biotechnology sector. Specializing in the development of therapies for..

ImmunityBio, Inc. (IBRX) Investor Outlook: Exploring a 330% Potential Upside in the Biotech Sector

ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage biotechnology company, is making waves in the healthcare sector with its innovative approach to cancer and infectious disease therapies. Based in San Diego, California,..

Perrigo Company plc (PRGO) Investor Outlook: A 29.75% Upside Potential Amidst Healthcare Sector Challenges

Perrigo Company plc (PRGO), a stalwart in the healthcare sector, is making headlines with its potential for a substantial 29.75% upside, a figure that has caught the attention of individual..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Impressive 104.60% Potential Upside and Strong Buy Ratings Capture Investor Attention

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is drawing significant attention in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization of $1.73 billion, the..

Catalyst Pharmaceuticals, Inc. (CPRX) Investor Outlook: Exploring a 64.84% Potential Upside

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) continues to capture investor attention with its promising growth trajectory and impressive stock potential. As a key player in the biotechnology sector, this Coral Gables,..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Understanding the 55% Potential Upside

Alignment Healthcare, Inc. (NASDAQ: ALHC), a prominent player in the healthcare plans industry, is catching the attention of investors, particularly with its notable growth potential. Based in Orange, California, and..

Amedisys Inc (AMED) Stock Analysis: Navigating Healthcare with a Promising 0.48% Upside

Amedisys Inc (AMED), a prominent player in the healthcare sector, operates within the medical care facilities industry, offering critical services across the United States. With a market capitalization of $3.18..

Metsera, Inc. (MTSR): Biotechnology’s Rising Star with a 45% Potential Upside

Metsera, Inc. (MTSR), a burgeoning name in the biotechnology sector, is catching the eye of savvy investors with its remarkable potential upside of 45.41%. This clinical-stage company, based in New..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Unpacking a 42.99% Potential Upside in the Biotechnology Sector

PTC Therapeutics, Inc. (NASDAQ: PTCT), a prominent player in the biotechnology sector, has been capturing investor attention with its robust product pipeline and strategic collaborations. The company, which focuses on..

Xenon Pharmaceuticals Inc. (XENE) Investor Outlook: Analyzing a 78% Potential Upside in the Biotech Space

In the ever-evolving landscape of biotechnology, Xenon Pharmaceuticals Inc. (NASDAQ: XENE) stands out as a notable player with a compelling narrative for investors seeking growth opportunities in the healthcare sector...

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: A Biotech with a 214.56% Potential Upside

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a prominent player in the biotechnology sector, has captured investor attention with an impressive potential upside of 214.56%. This biopharmaceutical company specializes in developing treatments..

Viking Therapeutics, Inc. (VKTX): Analyst Consensus Reveals a Striking 170% Potential Upside

In the fast-paced world of biotechnology, Viking Therapeutics, Inc. (NASDAQ: VKTX) stands out with its promising drug pipeline and significant potential upside. As a clinical-stage biopharmaceutical company, Viking Therapeutics focuses..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds